Cargando…
Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds
Cancer immunotherapy and the emergence of immune checkpoint inhibitors have markedly changed the treatment paradigm for many cancers. They function to disrupt cancer cell evasion of the immune response and activate sustained anti-tumor immunity. Oncolytic viruses have also emerged as an additional t...
Autores principales: | Sivanandam, Venkatesh, LaRocca, Christopher J., Chen, Nanhai G., Fong, Yuman, Warner, Susanne G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503136/ https://www.ncbi.nlm.nih.gov/pubmed/31080879 http://dx.doi.org/10.1016/j.omto.2019.04.003 |
Ejemplares similares
-
Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
por: LaRocca, Christopher J., et al.
Publicado: (2018) -
Oncolytic Virotherapy for Cancer: Clinical Experience
por: Chaurasiya, Shyambabu, et al.
Publicado: (2021) -
A New Role for Vitamin D: The Enhancement of Oncolytic Viral Therapy in Pancreatic Cancer
por: LaRocca, Christopher J., et al.
Publicado: (2018) -
A Novel Chimeric Poxvirus Encoding hNIS Is Tumor-Tropic, Imageable, and Synergistic with Radioiodine to Sustain Colon Cancer Regression
por: Warner, Susanne G., et al.
Publicado: (2019) -
Optimizing Oncolytic Viral Design to Enhance Antitumor Efficacy: Progress and Challenges
por: Chaurasiya, Shyambabu, et al.
Publicado: (2020)